INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-MIGRATION BY PEPTIDE AND ANTIBODY ANTAGONISTS OF THE ALPHA(V)BETA(3) INTEGRIN COMPLEX IS REVERSEDBY ACTIVATED CALCIUM CALMODULIN-DEPENDENT PROTEIN-KINASE-II/
C. Bilato et al., INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-MIGRATION BY PEPTIDE AND ANTIBODY ANTAGONISTS OF THE ALPHA(V)BETA(3) INTEGRIN COMPLEX IS REVERSEDBY ACTIVATED CALCIUM CALMODULIN-DEPENDENT PROTEIN-KINASE-II/, The Journal of clinical investigation, 100(3), 1997, pp. 693-704
The migration of vascular smooth muscle cells (VSMCs) is thought to pl
ay a key role In the pathogenesis of many vascular diseases and is reg
ulated by soluble growth factors/ chemoattractants as well as interact
ions with the extracellular matrix. We have studied the effects of ant
ibodies to rat beta 3 and human alpha(v) beta(3) integrins on the migr
ation of VSMCs. Both integrin antibodies as well as cyclic RGD peptide
s that bind to the vitronectin receptors alpha(v) beta(3) and alpha(v)
beta(5) significantly inhibited PDGF-directed migration. This resulte
d in a reduction in the accumulation of inositol (1,4,5) trisphosphate
and the activation of calcium/calmodulin-dependent protein kinase II
(CamKII), an important regulatory event in VSMC migration identified p
reviously. PDGF-directed VSMC migration in the presence of the anti-in
tegrin antibodies and cyclic RGD peptides was restored when intracellu
lar CamKII activity was elevated by either raising intracellular calci
um levels with the ionophore, ionomycin, or infecting with a replicati
on-defective recombinant adenovirus expressing a constitutively activa
ted CamKII cDNA (AdCMV.CKIID3). Rescue of rat VSMCs was also observed
in stably transfected cell lines expressing constitutively activated b
ut not wild-type CamKII, These observations identify a key intermediat
e in the regulation of VSMC migration by outside-in signaling from the
integrin alpha(v) beta(3).